Figure 5.
PXRD pattern. A, native Doc; B, F13 (PLA, 360 mg; Doc, 10 mg; oil, 0.9 ml); C, F12 (200 mg, 10 mg, 0.5 ml); D, F6 (200 mg, 18 mg, 0.9 ml); E, blank nanocapsules; F, native PVA; and G, native PLA 208.
PXRD pattern. A, native Doc; B, F13 (PLA, 360 mg; Doc, 10 mg; oil, 0.9 ml); C, F12 (200 mg, 10 mg, 0.5 ml); D, F6 (200 mg, 18 mg, 0.9 ml); E, blank nanocapsules; F, native PVA; and G, native PLA 208.